¹ú¼ÒÒ©¼à¾Ö×¢ÏúÝÊõÓÍÆÏÌÑÌÇ×¢ÉäÒºµÈ78¸öÒ©Æ·×¢²áÖ¤Êé
¡¡¡¡¸ù¾Ý¡¶ÖлªÈËÃñ¹²ºÍ¹úÒ©Æ·¹ÜÀí·¨ÊµÊ©ÌõÀý¡·ºÍ¡¶Ò©Æ·×¢²á¹ÜÀí°ì·¨¡·µÄÓйع涨£¬¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾Ö¾ö¶¨×¢ÏúÝÊõÓÍÆÏÌÑÌÇ×¢ÉäÒºµÈ78¸öÒ©Æ·×¢²áÖ¤Êé¡£
¡¡¡¡Ìش˹«¸æ¡£
¡¡¡¡¸½¼þ£º×¢ÏúÒ©Æ·×¢²áÖ¤ÊéĿ¼
ÐòºÅ
|
ҩƷͨÓÃÃû³Æ
|
Åú×¼ÎĺÅ
|
¼ÁÐÍ
|
¹æ¸ñ
|
Ò©Æ·ÉÏÊÐÐí¿É³ÖÓÐÈË
|
×¢ÏúÇéÐÎ
|
1
|
ÝÊõÓÍÆÏÌÑÌÇ×¢ÉäÒº
|
¹úÒ©×¼×ÖH20044181
|
×¢Éä¼Á
|
250ml:0.1gÝÊõÓÍÓë12.5gÆÏÌÑÌÇ
|
ÄÚÃɹŰ×Ò½ÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
2
|
Ñõ
|
¹úÒ©×¼×ÖH20045924
|
ÆøÌå
|
40L
|
ºôºÍºÆÌØÌú·ÑõÆø³§
|
ÒÀÉêÇë×¢Ïú
|
3
|
ÑÎËá±¶Ëû˾͡ÂÈ»¯ÄÆ×¢ÉäÒº
|
¹úÒ©×¼×ÖH15021430
|
×¢Éä¼Á
|
500£í£ì£ºÑÎËá±¶Ëû˾͡0.02£ç£¬ÂÈ»¯ÄÆ4.5g
|
ÄÚÃɹŰ×Ò½ÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
4
|
Çú¿Ë«¶¡ÂÈ»¯ÄÆ×¢ÉäÒº
|
¹úÒ©×¼×ÖH20059525
|
×¢Éä¼Á
|
100£í£ì£ºÇú¿Ë«¶¡0.4gÓëÂÈ»¯ÄÆ0.9g
|
ÄÚÃɹŰ×Ò½ÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
5
|
Ê®°ËζŷÇúÍè
|
¹úÒ©×¼×ÖZ20027806
|
Íè¼Á
|
ÿÍèÖØ0.5g£¨²ØÒ½£©Ã¿10ÍèÖØ2g£¨ÃÉÒ½£©
|
ÄÚÃɹſâÂ×ÃÉÒ©ÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
6
|
×¢ÉäÓÃÍ·æßßßÍªÄÆÊæ°ÍÌ¹ÄÆ
|
¹úÒ©×¼×ÖH20057403
|
×¢Éä¼Á
|
0.75g(º¬Í·æßßßͪ 0.5g Óë Êæ°Í̹ 0.25g)
|
»ÔÈðÖÆÒ©ÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
7
|
×¢ÉäÓÃÍ·æßßßÍªÄÆÊæ°ÍÌ¹ÄÆ
|
¹úÒ©×¼×ÖH20020598
|
×¢Éä¼Á
|
3.0g(C25H27N9O8S2 2.0g ÓëC8H11NO5S 1.0g)
|
»ÔÈðÖÆÒ©ÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
8
|
Æ¥¶àĪµÂ½ºÄÒ
|
¹úÒ©×¼×ÖH20090359
|
½ºÄÒ¼Á
|
0.4g
|
ÄϾ©º£³½Ò©Òµ¹É·ÝÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
9
|
¼×ÏõßòÂÈ»¯ÄÆ×¢ÉäÒº
|
¹úÒ©×¼×ÖH34021677
|
×¢Éä¼Á
|
250ml:¼×Ïõßò0.5gÓëÂÈ»¯ÄÆ2.25g
|
°²»Õ¸»°îÒ©ÒµÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
10
|
¸ÊÓ͹ûÌÇÂÈ»¯ÄÆ×¢ÉäÒº
|
¹úÒ©×¼×ÖH20057114
|
×¢Éä¼Á
|
250ml:¸ÊÓÍ25g,¹ûÌÇ12.5g,ÂÈ»¯ÄÆ2.25g
|
³½ÐÀÒ©Òµ¹É·ÝÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
11
|
¿à²ÎËØ·ÖɢƬ
|
¹úÒ©×¼×ÖH20080045
|
Ƭ¼Á
|
0.1g(°´Ñõ»¯¿à²Î¼îC15H24N2O2¼Æ)
|
Ò˲ý¶«Ñô¹â³¤½Ò©Òµ¹É·ÝÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
12
|
°±·Ç¿§Æ¬
|
¹úÒ©×¼×ÖH64020255
|
Ƭ¼Á
|
ÿƬº¬°±»ù±ÈÁÖ100mg¡¢·ÇÄÇÎ÷¶¡150mgºÍ¿§ ·È Òò45mg
|
ÄþÏÄÆôÔª¹úÒ©ÓÐÏÞ¹«Ë¾
|
ÒÀÉêÇë×¢Ïú
|
13
|
¾ÛάͪµâÈÜÒº
|
¹úÒ©×¼×ÖH62020419
|
ÈÜÒº¼Á
|
100ml:7.5g
|
½ð²ý½ðµ¤Ò©ÒµÓÐÏÞ¹«Ë¾
|
²»ÓèÔÙ×¢²á
|
14
|
¾ÛάͪµâÈÜÒº
|
¹úÒ©×¼×ÖH62020420
|
ÈÜÒº¼Á
|
100ml:5g
|
½ð²ý½ðµ¤Ò©ÒµÓÐÏÞ¹«Ë¾
|
²»ÓèÔÙ×¢²á
|
15
|
¾ÛάͪµâÈÜÒº
|
¹úÒ©×¼×ÖH62020435
|
ÈÜÒº¼Á
|
100ml:10g
|
½ð²ý½ðµ¤Ò©ÒµÓÐÏÞ¹«Ë¾
|
²»ÓèÔÙ×¢²á
|
16
|
¾ÛάͪµâÈÜÒº
|
¹úÒ©×¼×ÖH62021266
|
ÈÜÒº¼Á
|
1%
|
½ð²ý½ðµ¤Ò©ÒµÓÐÏÞ¹«Ë¾
|
²»ÓèÔÙ×¢²á
|
17
|
±ûÐ͸ÎÑײ¡¶¾¿¹ÌåÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
¹úÒ©×¼×ÖS19980199
|
ÌåÍâÕï¶ÏÊÔ¼Á
|
48ÈË·Ý
|
À¼Öݱê¼ÑÉúÎï¼¼ÊõÓÐÏÞ¹«Ë¾
|
²»ÓèÔÙ×¢²á
|
18
|
ÒÒÐ͸ÎÑײ¡¶¾±íÃæ¿¹ÔÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
¹úÒ©×¼×ÖS19980088
|
ÌåÍâÕï¶ÏÊÔ¼Á
|
96ÈË·Ý
|
À¼Öݱê¼ÑÉúÎï¼¼ÊõÓÐÏÞ¹«Ë¾
|
²»ÓèÔÙ×¢²á
|
19
|
ÒÒÐ͸ÎÑײ¡¶¾±íÃæ¿¹ÔÕï¶ÏÊÔ¼ÁºÐ
|
¹úÒ©×¼×ÖS19980091
|
ÌåÍâÕï¶ÏÊÔ¼Á
|
48ÈË·Ý
|
À¼Öݱê¼ÑÉúÎï¼¼ÊõÓÐÏÞ¹«Ë¾
|
²»ÓèÔÙ×¢²á
|
20
|
±ûÐ͸ÎÑײ¡¶¾¿¹ÌåÕï¶ÏÊÔ¼ÁºÐ
|
¹úÒ©×¼×ÖS19980084
|
ÌåÍâÕï¶ÏÊÔ¼Á
|
96ÈË·Ý
|
À¼Öݱê¼ÑÉúÎï¼¼ÊõÓÐÏÞ¹«Ë¾
|
²»ÓèÔÙ×¢²á
|
21
|
ÊóÒß¾úÕï¶ÏѪÇå
|
¹úÒ©×¼×ÖS10820132
|
ÌåÍâÕï¶ÏÊÔ¼Á
|
2ml
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
22
|
ÊóÒß¾úF1¿¹ÌåÕï¶ÏÊÔ¼Á(ѪÄý·¨)
|
¹úÒ©×¼×ÖS10820129
|
ÌåÍâÕï¶ÏÊÔ¼Á
|
1ml
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
23
|
ÒÒÐ͸ÎÑײ¡¶¾e¿¹ÔÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
¹úÒ©×¼×ÖS10910036
|
Õï¶ÏÊÔ¼ÁºÐ
|
48ÈË·Ý/ºÐ
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
24
|
¿¨½é¾ú´¿µ°°×ÑÜ»¯Îï
|
¹úÒ©×¼×ÖS10940023
|
ÌåÄÚÕï¶ÏÊÔ¼Á
|
50IU/ml
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
25
|
ÒÒÐ͸ÎÑײ¡¶¾ºËÐÄ¿¹ÌåÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
¹úÒ©×¼×ÖS10910042
|
Õï¶ÏÊÔ¼ÁºÐ
|
96ÈË·Ý/ºÐ
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
26
|
ÒÒÐ͸ÎÑײ¡¶¾±íÃæ¿¹ÌåÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
¹úÒ©×¼×ÖS10910039
|
Õï¶ÏÊÔ¼ÁºÐ
|
96ÈË·Ý/ºÐ
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
27
|
Îý¿ËÊÔÑé¶¾ËØ
|
¹úÒ©×¼×ÖS10820134
|
ÌåÍâÕï¶ÏÊÔ¼Á
|
10ÈË·Ý
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
28
|
ÂÖ×´²¡¶¾Õï¶ÏÊÔ¼ÁºÐ
|
¹úÒ©×¼×ÖS10870016
|
Õï¶ÏÊÔ¼ÁºÐ
|
48ÈË·Ý
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
29
|
ÒÒÐ͸ÎÑײ¡¶¾e¿¹ÔÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
¹úÒ©×¼×ÖS10910037
|
Õï¶ÏÊÔ¼ÁºÐ
|
96ÈË·Ý/ºÐ
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
30
|
ÒÒÐ͸ÎÑײ¡¶¾e¿¹ÌåÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
¹úÒ©×¼×ÖS10910035
|
Õï¶ÏÊÔ¼ÁºÐ
|
96ÈË·Ý/ºÐ
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
31
|
ÒÒÐ͸ÎÑײ¡¶¾ºËÐÄ¿¹ÌåÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
¹úÒ©×¼×ÖS10910043
|
Õï¶ÏÊÔ¼ÁºÐ
|
48ÈË·Ý/ºÐ
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
32
|
ÒÒÐ͸ÎÑײ¡¶¾e¿¹ÌåÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
¹úÒ©×¼×ÖS10910044
|
Õï¶ÏÊÔ¼ÁºÐ
|
48ÈË·Ý/ºÐ
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
33
|
ÒÒÐ͸ÎÑײ¡¶¾±íÃæ¿¹ÌåÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
¹úÒ©×¼×ÖS10910038
|
Õï¶ÏÊÔ¼ÁºÐ
|
48ÈË·Ý/ºÐ
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
34
|
ÄÔĤÑ×ÄÎɪÊϾúÕï¶ÏѪÇå
|
¹úÒ©×¼×ÖS10820076
|
ÌåÍâÕï¶ÏÊÔ¼Á
|
1ml
|
À¼ÖÝÉúÎïÖÆÆ·Ñо¿Ëù
|
²»ÓèÔÙ×¢²á
|
35
|
С°Ü¶¾¸à
|
¹úÒ©×¼×ÖZ12020164
|
¼å¸à¼Á(¸à×Ì)
|
ÿƿװ60g;ÿƿװ120g;ÿƿװ180g;ÿ´ü×°10g;ÿ´ü×°15g
|
Ìì½òÊв©°®ÉúÎïÒ©ÒµÓÐÏÞ¹«Ë¾
|
ÒÀ·¨µõÏú
|
36
|
Ê¥·Ô¼º²²Ý(¹áÒ¶½ðË¿ÌÒ)ÌáÈ¡Îï
|
Z20120001
|
ÔÁÏÒ©
|
ÿͰװ50kg
|
Dr. Willmar Schwabe GmbH & Co. KG
|
ÒÀÉêÇë×¢Ïú
|
37
|
±ûÐ͸ÎÑײ¡¶¾¿¹ÌåÕï¶ÏÊÔ¼ÁºÐ(øÁªÃâÒß·¨)
|
S20140098
|
Õï¶ÏÊÔ¼ÁºÐ
|
96ÈË·Ý/ºÐ
|
DiaSorin South Africa (Proprietary) Limited
|
ÒÀÉêÇë×¢Ïú
|
38
|
°®»îµ¨Í¨Èí½ºÄÒ
|
Z20201000
|
½ºÄÒ¼Á
|
ÿÁ£×°0.2g(Ï൱ÓÚÅ·»îѪµ¤0.2g)
|
Pharmazeutische Fabrik Evers GmbH & Co.KG
|
ÒÀÉêÇë×¢Ïú
|
39
|
À´ÇúßòƬ
|
¹úÒ©×¼×ÖHJ20200030
|
Ƭ¼Á
|
2.5mg
|
Fresenius Kabi Oncology Limited
|
ÒÀÉêÇë×¢Ïú
|
40
|
±È¿¨Â³°·Æ¬
|
H20190033
|
Ƭ¼Á
|
50mg
|
Fresenius Kabi Oncology Limited
|
ÒÀÉêÇë×¢Ïú
|
41
|
×¢ÉäÓð¢ÆæÃ¹ËØ
|
H20160579
|
×¢Éä¼Á
|
0.5g(50Íòµ¥Î»)
|
Pliva Croatia Ltd.
|
ÒÀÉêÇë×¢Ïú
|
42
|
ÄÇËûÃ¹ËØµÎÑÛÒº
|
H20171229
|
µÎÑÛ¼Á
|
15ml:0.75g
|
Novartis pharmaceuticals Corporation
|
ÒÀÉêÇë×¢Ïú
|
43
|
ÒÀ´ïÀ·î×¢ÉäÒº
|
H20190045
|
×¢Éä¼Á
|
100ml:30mg
|
Mitsubishi Tanabe Pharma Corporation
|
ÒÀÉêÇë×¢Ïú
|
44
|
ÒÀ´ïÀ·î×¢ÉäÒº
|
H20201002
|
×¢Éä¼Á
|
100ml:30mg
|
Mitsubishi Tanabe Pharma Corporation
|
ÒÀÉêÇë×¢Ïú
|
45
|
ÒÀ´ïÀ·î×¢ÉäÒº
|
¹úÒ©×¼×ÖJ20200009
|
×¢Éä¼Á
|
100ml:30mg
|
Mitsubishi Tanabe Pharma Corporation
|
ÒÀÉêÇë×¢Ïú
|
46
|
Ë«¼ÛÈËÈéÍ·Áö²¡¶¾Îü¸½ÒßÃç
|
¹úÒ©×¼×ÖSJ20160026
|
×¢Éä¼Á
|
0.5ml/Æ¿£¨º¬HPV-16 L1µ°°×ºÍHPV-18 L1µ°°×¸÷20μg)
|
GlaxoSmithKline Biologicals S.A.
|
ÒÀÉêÇë×¢Ïú
|
47
|
Ë«¼ÛÈËÈéÍ·Áö²¡¶¾Îü¸½ÒßÃç
|
¹úÒ©×¼×ÖSJ20160027
|
×¢Éä¼Á
|
0.5ml/Æ¿£¨º¬HPV-16 L1µ°°×ºÍHPV-18 L1µ°°×¸÷20μg)
|
GlaxoSmithKline Biologicals S.A.
|
ÒÀÉêÇë×¢Ïú
|
48
|
×¢ÉäÓð¬ÅµÄýÑªËØα
|
¹úÒ©×¼×ÖSJ20210009
|
×¢Éä¼Á
|
250IU/Æ¿
|
Bioverativ Therapeutics, Inc
|
ÒÀÉêÇë×¢Ïú
|
49
|
×¢ÉäÓð¬ÅµÄýÑªËØα
|
¹úÒ©×¼×ÖSJ20210010
|
×¢Éä¼Á
|
500IU/Æ¿
|
Bioverativ Therapeutics, Inc
|
ÒÀÉêÇë×¢Ïú
|
50
|
×¢ÉäÓð¬ÅµÄýÑªËØα
|
¹úÒ©×¼×ÖSJ20210011
|
×¢Éä¼Á
|
1000IU/Æ¿
|
Bioverativ Therapeutics, Inc
|
ÒÀÉêÇë×¢Ïú
|
51
|
×¢ÉäÓð¬ÅµÄýÑªËØα
|
¹úÒ©×¼×ÖSJ20210012
|
×¢Éä¼Á
|
2000IU/Æ¿
|
Bioverativ Therapeutics, Inc
|
ÒÀÉêÇë×¢Ïú
|
52
|
³¦ÄÚÓªÑøÈé¼Á£¨TPF-T£©
|
H20130820
|
¿Ú·þÈé¼Á
|
500ml/´ü£¨ÖÐÐÔ¿Ú棩
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
53
|
³¦ÄÚÓªÑøÈé¼Á£¨TPF-T£©
|
H20130819
|
¿Ú·þÈé¼Á
|
500ml/´ü£¨ÖÐÐÔ¿Ú棩
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
54
|
³¦ÄÚÓªÑøÈé¼Á£¨TPF-T£©
|
¹úÒ©×¼×ÖJ20130177
|
¿Ú·þÈé¼Á
|
500ml/´ü£¨ÖÐÐÔ¿Ú棩
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
55
|
³¦ÄÚÓªÑøÈé¼Á(TPF-D)
|
H20140189
|
¿Ú·þÈé¼Á
|
500ml/Æ¿
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
56
|
³¦ÄÚÓªÑøÈé¼Á(TPF-D)
|
H20140190
|
¿Ú·þÈé¼Á
|
500ml/Æ¿
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
57
|
³¦ÄÚÓªÑøÈé¼Á(TPF-D)
|
¹úÒ©×¼×ÖJ20140078
|
¿Ú·þÈé¼Á
|
500ml/Æ¿
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
58
|
³¦ÄÚÓªÑøÈé¼Á(TPF-D)
|
H20140192
|
¿Ú·þÈé¼Á
|
500ml/Æ¿
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
59
|
³¦ÄÚÓªÑøÈé¼Á(TPF-D)
|
H20140191
|
¿Ú·þÈé¼Á
|
500ml/Æ¿
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
60
|
³¦ÄÚÓªÑøÈé¼Á(TPF-D)
|
¹úÒ©×¼×ÖJ20140077
|
¿Ú·þÈé¼Á
|
500ml/Æ¿
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
61
|
³¦ÄÚÓªÑøÈé¼Á(TPF-D)
|
H20140193
|
¿Ú·þÈé¼Á
|
1000ml/Æ¿
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
62
|
³¦ÄÚÓªÑøÈé¼Á(TPF-D)
|
H20140194
|
¿Ú·þÈé¼Á
|
1000ml/Æ¿
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
63
|
³¦ÄÚÓªÑøÈé¼Á(TPF-D)
|
¹úÒ©×¼×ÖJ20140112
|
¿Ú·þÈé¼Á
|
1000ml/Æ¿
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
64
|
³¦ÄÚÓªÑøÈé¼Á(TP)
|
H20140223
|
¿Ú·þÈé¼Á
|
500ml/´ü
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
65
|
³¦ÄÚÓªÑøÈé¼Á(TP)
|
H20140255
|
¿Ú·þÈé¼Á
|
500ml/´ü
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
66
|
³¦ÄÚÓªÑøÈé¼Á(TP)
|
¹úÒ©×¼×ÖJ20140075
|
¿Ú·þÈé¼Á
|
500ml/´ü
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
67
|
³¦ÄÚÓªÑøÈé¼Á(TP-HE)
|
H20130845
|
¿Ú·þÈé¼Á
|
500ml/´ü
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
68
|
³¦ÄÚÓªÑøÈé¼Á(TP-HE)
|
H20130846
|
¿Ú·þÈé¼Á
|
500ml/´ü
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
69
|
³¦ÄÚÓªÑøÈé¼Á(TP-HE)
|
¹úÒ©×¼×ÖJ20130178
|
¿Ú·þÈé¼Á
|
500ml/´ü
|
Fresenius Kabi Deutschland GmbH
|
ÒÀÉêÇë×¢Ïú
|
70
|
°¢Î÷ÃÀÐÁ»ºÊͽºÄÒ
|
H20130600
|
½ºÄÒ¼Á
|
90mg
|
Mylan Healthcare GmbH
|
ÒÀÉêÇë×¢Ïú
|
71
|
èÛéÚËá°¢¶ûάÁÖ½ºÄÒ
|
H20140183
|
½ºÄÒ¼Á
|
60mg
|
Mylan Products Limited
|
ÒÀÉêÇë×¢Ïú
|
72
|
άÉúËØCÅÝÌÚÆ¬
|
¹úÒ©×¼×ÖHJ20140845
|
Ƭ¼Á
|
1000mg
|
Bayer(Schweiz)AG
|
ÒÀÉêÇë×¢Ïú
|
73
|
ÂÈ»¯ïÈ[89Sr]×¢ÉäÒº
|
H20140617
|
×¢Éä¼Á
|
150MBq(4mCi)/4mL
|
GE HEALTHCARE LIMITED
|
ÒÀÉêÇë×¢Ïú
|
74
|
×¢ÉäÓÃÂÈŵÎô¿µ
|
H20150236
|
×¢Éä¼Á
|
8mg(ÿƿʵװ8.6mg)
|
Takeda Austria GmbH
|
ÒÀÉêÇë×¢Ïú
|
75
|
¶þ¼×Ë«ëÒά¸ñÁÐ͡Ƭ(¢ó)
|
¹úÒ©×¼×ÖHJ20171035
|
Ƭ¼Á
|
ÿƬº¬ÑÎËá¶þ¼×Ë«ëÒ1000mgºÍά¸ñÁÐÍ¡50mg
|
Novartis Pharma Schweiz AG
|
ÒÀÉêÇë×¢Ïú
|
76
|
±È¿¨Â³°·Æ¬
|
¹úÒ©×¼×ÖHJ20200061
|
Ƭ¼Á
|
50mg
|
Sun Pharmaceutical Industries Limited
|
ÒÀÉêÇë×¢Ïú
|
77
|
ÑÎËá°ºµ¤Ë¾Çí×¢ÉäÒº
|
H20170314
|
×¢Éä¼Á
|
2ml:4mg
|
Novartis Pharma Schweiz AG
|
ÒÀÉêÇë×¢Ïú
|
78
|
ÑÎËá°ºµ¤Ë¾Çí×¢ÉäÒº
|
H20170315
|
×¢Éä¼Á
|
4ml:8mg
|
Novartis Pharma Schweiz AG
|
ÒÀÉêÇë×¢Ïú
|
¡¡¡¡¹ú¼ÒÒ©¼à¾Ö
¡¡¡¡2022Äê11ÔÂ22ÈÕ
¡¾°æÈ¨ÉùÃ÷¡¿±ü³Ð»¥ÁªÍø¿ª·Å¡¢°üÈݵľ«Éñ£¬Ò½Ò©Íø»¶Ó¸÷·½(×Ô)ýÌå¡¢»ú¹¹×ªÔØ¡¢ÒýÓÃÎÒÃÇÔ´´ÄÚÈÝ£¬µ«ÒªÑϸñ×¢Ã÷À´Ô´Ò½Ò©Íø£»Í¬Ê±£¬ÎÒÃdz«µ¼×ðÖØÓë±£»¤ÖªÊ¶²úȨ£¬Èç·¢ÏÖ±¾Õ¾ÎÄÕ´æÔÚ°æÈ¨ÎÊÌ⣬·³Ç뽫°æÈ¨ÒÉÎÊ¡¢ÊÚȨ֤Ã÷¡¢°æÈ¨Ö¤Ã÷¡¢ÁªÏµ·½Ê½µÈ£¬·¢ÓʼþÖÁpharmnet@netsun.com£¬ÎÒÃǽ«µÚһʱ¼äºËʵ¡¢´¦Àí¡£
- Ïà¹Ø±¨µÀ
-
- ÒÔÁëÒ©Òµ£ºÁ¬»¨ÇåÎÁ½ºÄÒ»ñÄáÈÕÀûÑÇÒ©Æ·×¢²áÖ¤Êé(2022-05-11)
- ¹ú¼ÒÒ©¼à¾Ö×¢Ïú210¸öÒ©Æ·×¢²áÖ¤Êé¡¢6¸öÒ½ÁÆÆ÷еע²áÖ¤Êé(2021-12-15)
- ¹ú¼ÒÒ©¼à¾Ö×¢ÏúС¶ù·Ó°±¿§Ãô¿ÅÁ£µÈ8¸öÆ·ÖÖÒ©Æ·×¢²áÖ¤Êé(2021-11-17)
- ÑÎËáÁÖ¿ÉÃ¹ËØ½ºÄÒµÈ46¸öÒ©Æ·×¢²áÖ¤Êé±»×¢Ïú(2021-09-01)
- ¹ú¼ÒÒ©¼à¾Ö¹ØÓÚ×¢ÏúÆÏÌÑÌÇ×¢ÉäÒºµÈ42¸öÒ©Æ·×¢²áÖ¤ÊéµÄ¹«¸æ(2021-06-28)
- ¹úÄÚÆóҵƷÖÖÊÝÉí ´ÓÒ©Æ·×¢²áÖ¤Êé×¢Ïú¿´²úÒµ±ä»¯(2021-06-25)
